INTRODUCTION

In immune and inflammatory responses, virus infection results in activation or
. Besides IFN genes, many other genes such as the tumor suppressor p53 (14) , the transporter associated with antigen processing 2 (Tap2) (15) and the EBV latent membrane oncoprotein 1 (LMP1) (16) , possess ISRE motifs and are regulated by IRFs. Since these genes are involved in cell-cycle regulation, apoptosis and tumor suppression, IRFs are also involved in regulation of these processes in addition to their roles in immune regulation (17) (18) (19) . Two such sequence motifs, 5'-GGAAAGCGAAACC-3' (ISRE) and 5'-CAAAAGCGAAACT-3' (IRF-binding element, IRFE), have been identified in the IRF7 first intron and in its promoter, respectively (20) .
IRF7 has a wider DNA-binding specificity (GAAWNYGAAANY, W = A or T, Y=C or T) compared with IRF3 (GAAASSGAAANY, S=G or C) (21) . Studies on murine IFNA promoters showed that the core sequence GAAANN for IRF binding can be divided into four groups according to the identity of the NN: 1, the NC (N=G, C, A, or T) and ST bases inducible by both IRF3 and IRF7; 2, the NG and CA preferentially responsive to IRF3; 3, the GAAAAT repeats responding only to IRF7; and 4, the DA (D=T, A, or G) unresponsive to both factors (7;22) . Interestingly, both the IRF7 ISRE and IRFE match the first group which is inducible by both IRF3 and IRF7.
The ISRE-containing genes are regulated by IRFs typically through the Jak-STAT pathway.
In this pathway, type I or II IFN stimulation results in the phosphorylation of STAT1 and STAT2. The phosphorylated STAT1 and STAT2, together with IRF9 which is constitutively expressed in most cell types, form the complex, interferon-stimulated gene factor 3 (ISGF3) (23) . This complex binds to the ISREs in the ISRE-containing genes and activates their transcription. A single copy of ISRE is sufficient for gene activation, but ISRE-containing genes are not inducible in mutant cell lines in which any Jak-STAT pathway component has been knocked out (10;24) . Expression of IRF7 is typically mediated by the IFN-triggered Jak-STAT pathway, in which ISGF3 directly binds to the IRF7 ISRE (20;25).
Although virus infection or synthetic dsRNA results in expression of type I IFNs, which induce expression of IFN-inducible genes, some of these IFN-inducible genes such as ISG15/54/56, are also directly induced upon virus infection or by dsRNA independent of the IFN-triggered Jak-STAT pathway (24;26-30) . The IRF family member, IRF1, is also induced by both IFN and direct virus infection independent of IFN signaling (9;31). Other IFN-inducible genes such as ISG9-27 and ISG6-16, however, are only induced by IFNs, but not by virus infection or dsRNA (3;32). Thus, it seems that virus infection and IFN trigger two distinct cellular pathways, which sometimes converge on the same cis-acting elements. The slight differences in the ISRE motifs in the promoters of these ISRE-containing genes confer their different specificity in inducibility by either IFN or virus through unknown mechanisms (3). IRF7 functions as either an activator or a repressor in regulation of some ISRE-containing genes. In addition to induction of type I IFN expression (33;34), IRF7 also represses EBNA1 transcription in Epstein-Barr virus (EBV) type III latency (35) , activates Tap2 transcription via EBV LMP1 (15) , and induces LMP1 expression (16) .
Although extensive studies have shown that IRF7 is a multifunctional protein whose transcriptional activity depends on C-terminal phosphorylation, regulation of the IRF7 promoter (IRF7p) is poorly understood. Previous data show that ISGF3 is a potent factor in the induction of IRF7 expression in mouse (25) and human cells (20) . In this study, in addition to induction by type I IFNs, we demonstrate that IRF7 transcription can be regulated by binding of both IRF7 and IRF3 proteins in the virus-activated factor (VAF) complex to the IRF7p ISRE and IRFE, and that this regulation is independent of the IFN pathway.
EXPERIMENTAL PROCEDURES
PLASMIDS
The IRF7 promoter construct p(-1123/+575)-Luc, which contains the wild type ISRE and IRFE motifs, as well as its three mutants, IRFEm-Luc, (ISRE+IRFE)m-Luc, and ∆ISRE-Luc, were gifts from Paul Pitha (20) . ISREm-Luc and ∆IRFE-Luc were made by site-directed mutation (Stratagene) using p(-1123/+575)-Luc as template. The IFNβ promoter construct, pGL3/IFNβp-Luc was described previously (36) . The expression plasmids IRF7 (35), Flag-IRF7 and its mutants (36) , IRF3 and IRF3(5D) were described previously (29) . The Zinc-inducible kinase-inactive Jak1 (Jak1 K896R) cDNA cloned in MTCB6+ vector was kindly provided by Paul Rothman (37) . Both pMTCB6+-Jak1DN and EGFP-C1 vector contain a neomycin resistance gene which allows transfected cells to be selected using G418. Flag-IRF7DN, Flag-IRF3, Flag-IRF3DN and Flag-IRF3(5D) were constructed by subcloning corresponding PCR products into pCMV2-Flag vector (Sigma) which was kindly provided by John Hiscott. The whole cell lysates were used for EMSA, as described previously (36) . Poly (dI-dC) antibody N-15 (Santa Cruz) before probe was added. Protein-DNA complexes were separated on 5% 60:1 acrylamide/bis-acrylamide gels.
CELL LINES AND ESTABLISHMENT OF STABLE TRANSFECTANTS
CHROMATIN IMMUNOPRECIPITATION ASSAY
HeLa cells in 100-mm dishes were transfected with 5 µg of expression plasmids or empty vector. Cells were infected with SeV for 6 h and then subjected to crosslinking by adding formaldehyde to a final concentration of 1% for 30 min at room temperature with slow rotation. Crosslinking was stopped by adding glycine to a final concentration of 125 mM for 5 min. Chromatin was sheared to approximately 300 bp by sonication. Immunoprecipitation, washing and the recovery of bound DNA were performed following the protocol provided by Upstate. After extraction and precipitation, DNA pellets were dissolved in 60 µl H 2 O, and 15 µl of each were used for PCR. All PCR reactions were performed for 35 cycles with a high fidelity PCR system (Roche) at an annealing temperature of 60℃. PCR products were run on 1.5% agarose gels.
RT-PCR
Cells were infected with 200 HAU/ml of SeV or 500 U/ml IFNα2 (Sigma) for indicated time periods. RT was performed for 60 min in a volume of 20 µl with 1 µg of total RNA with an RT-PCR system kit (Promega). The cDNA products were diluted 5 times. PCR was run in the linear range (30 cycles) at an annealing temperature of 60℃ in a high fidelity PCR system (Roche). Primers for β-actin were: 5'-GGCATCGTGATGGACTCCG-3' and 5'-GCTGGAAGGTGGACAGCGA-3'. PCR products were run on 1.5% agarose gels.
RESULTS
VIRUS INFECTION INDUCES ENDOGENOUS IRF7 MRNA
IRF7 possesses an ISRE and an IRFE in its promoter and first intron (20) . IRF3 and IRF7
can potentially bind to these elements after activation by virus infection, and therefore (Fig 3B) , implying that the ISRE, but not the IRFE, may account for the high constitutive activity. Similar to the wild type construct p(-1123/+575)-Luc, activation was still detected with mutation or deletion of either the ISRE or IRFE motif. However, mutation in both the ISRE and IRFE led to complete loss of the response to IRF3 and IRF7 (Fig 3B) . These data indicate that both the ISRE and IRFE contribute to activation of IRF7p by IRF3 and IRF7, but that the ISRE is chiefly responsible.
IRF3 AND IRF7 BIND TO THE IRF7 PROMOTER AS CONSTITUENTS OF THE COMPLEX VAF
To show whether IRF7 and IRF3 bind directly to the ISRE and IRFE of IRF7p, EMSA was performed with the use of synthesized IRF7p ISRE and IRFE as probes. As shown in Fig 4A, in vector-transfected cells, no specific band was detected (Fig 4A, lane 1 ), but after virus infection a very weak specific band appeared (Fig 4A, lane 2) . The specificity of the band was demonstrated by competition assays with AP1 oligomers (data not shown). In all other cell lysates transfected with IRF7 or IRF3 or both, more intense bands of the same size were detected (Fig 4A, lanes 3-10) . The bands became much stronger after SeV infection (Fig 4A,   lanes 4, 6, 8 and 10, compared with lanes 3, 5, 7, and 9, respectively). An interesting feature of the specific band detected by EMSA is that regardless of the plasmid(s) transfected and whether the cells were infected with SeV or not, all the bands are of the same size. Thus, it is most likely that IRF7 and IRF3 bind to the ISRE as part of the VAF complex in both uninfected and SeV-infected cells since VAF forms upon virus infection and includes both IRF3 and IRF7 (3).
To be sure that the bands represent VAF-DNA complex, the sample transfected with Flag-IRF7 and IRF3 was subjected to supershift analyses with antibodies against Flag, IRF3, p300 and CBP. The results show that, besides IRF7 and IRF3, these bands contain p300
and CBP (Fig 4A, lanes 11, 12, 15 and 16 ). We also compared binding and supershift of the VAF complex with the PRD31 probe from IFNβp. As expected, for both the ISRE of IRF7p and PRD31 of IFNβp, the bands detected were the same size, were completely shifted by Flag antibody, and completely blocked by the IRF3 antibody. The CBP and p300 antibodies are not as robust, but still shifted most of the complex (Fig 4B, lanes 3-10) . The polyclonal IRF7 antibody H-246 (Santa Cruz) does not have access to IRF7 in this complex since it can not produce a shift. The increase of VAF binding may be due to virus-induced phosphorylation of IRF3 and IRF7, which results in formation of more VAF complexes (3).
Also, we found that both IRF7 and IRF3 can bind to the IRF7p IRFE (Fig 4C) . Thus, these results indicate that IRF3 and IRF7 bind directly to the IRF7p ISRE and IRFE as part of the complex VAF.
IRF7 AND IRF3 BIND TO THE ENDOGENOUS IRF7 PROMOTER
The and IRF3 bind to either or both ISRE and IRFE of the endogenous IRF7 promoter in addition to VRE of IFNβp. Since the promoter-reporter assays (Fig 3) show that IRF3 and IRF7 can activate IRF7 ISRE and IRFE reporter constructs separately, and the EMSA results (Fig 4) show that IRF3 and IRF7 can bind to these two elements in vitro separately, and we sheared the DNA to approximately 300 bp whereas these two elements are approximately 600 bp apart, it is most likely that IRF3 and IRF7 bind to both the endogenous ISRE and IRFE elements.
DISCUSSION
Our results clearly show that IRF7 is a gene that can be induced directly by binding of VAF to its ISRE and IRFE upon SeV infection, and this induction is independent of the IFN-triggered Jak-STAT pathway (Fig 6A) . Our previous reports showed that EBV LMP1 can induce IRF7 expression through an unknown mechanism in addition to promoting phosphorylation of IRF7 protein (52;53) . Also, TNFα has been reported to induce IRF7 expression through activation of NFκB, which can bind to the NFκB-binding site identified in IRF7p (41). Besides these factors, IRF7 transcription is also thought to be regulated by promoter methylation and chromatin accessibility based on the observations that reagents that loosen chromatin Building on previous data on type I IFN regulation and IRF7 regulation, we propose a regulatory network between type I IFNs and IRF7 (Fig 6B) . Finally, these findings may impinge on the role of IRF7 in latent EBV infection. We have reported that IRF7 can induce the endogenous LMP1 promoter via its ISRE and restore LMP1 protein levels in a deficient cell line P3HR1 (16) . The circuit proposed here may also indirectly affect levels of this important viral oncoprotein. 
